These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2308952)

  • 1. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.
    Barton NW; Furbish FS; Murray GJ; Garfield M; Brady RO
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1913-6. PubMed ID: 2308952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
    Rosenthal DI; Doppelt SH; Mankin HJ; Dambrosia JM; Xavier RJ; McKusick KA; Rosen BR; Baker J; Niklason LT; Hill SC
    Pediatrics; 1995 Oct; 96(4 Pt 1):629-37. PubMed ID: 7567322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.
    Furbish FS; Blair HE; Shiloach J; Pentchev PG; Brady RO
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3560-3. PubMed ID: 269414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme replacement therapy for Gaucher disease in Australia.
    Goldblatt J; Szer J; Fletcher JM; McGill J; Rowell JA; Wilson M
    Intern Med J; 2005 Mar; 35(3):156-61. PubMed ID: 15737135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.
    Dale GL; Beutler E
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4672-4. PubMed ID: 1070017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintigraphic monitoring of reticuloendothelial system in patients with type 1 Gaucher disease on enzyme replacement therapy.
    Lorberboym M; Pastores GM; Kim CK; Hermann G; Glajchen N; Machac J
    J Nucl Med; 1997 Jun; 38(6):890-5. PubMed ID: 9189137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.
    Beutler E; Dale GL; Guinto DE; Kuhl W
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4620-3. PubMed ID: 200923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.
    Weinreb NJ; Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Rosenbloom BE; Scott CR; Wappner RS; Zimran A
    Am J Med; 2002 Aug; 113(2):112-9. PubMed ID: 12133749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of skeletal changes in type 1 Gaucher disease with enzyme replacement therapy.
    Pastores GM; Hermann G; Norton KI; Lorberboym M; Desnick RJ
    Skeletal Radiol; 1996 Jul; 25(5):485-8. PubMed ID: 8837283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large scale purification of glucocerebrosidase from human placentas.
    Dale GL; Beutler E; Fournier P; Blanc P; Liautaud J
    Birth Defects Orig Artic Ser; 1980; 16(1):33-41. PubMed ID: 6778526
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enzyme replacement therapy: a new treatment concept in Gaucher disease].
    Beck M; Mengel E; Barone R
    Wien Klin Wochenschr; 1997 Feb; 109(3):81-5. PubMed ID: 9139464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for enzyme replacement therapy in Gaucher disease.
    Brady RO; Barranger JA; Furbish FS; Stowens DW; Ginns EI
    Prog Clin Biol Res; 1982; 95():669-80. PubMed ID: 7122643
    [No Abstract]   [Full Text] [Related]  

  • 14. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.
    Heitner R; Arndt S; Levin JB
    S Afr Med J; 2004 Aug; 94(8):647-51. PubMed ID: 15352589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant macrophage targeted enzyme replacement therapy for Gaucher disease in India.
    Nagral A; Mewawalla P; Jagadeesh S; Kabra M; Phadke SR; Verma IC; Puri RD; Gupta N; Kishnani PS; Mistry PK
    Indian Pediatr; 2011 Oct; 48(10):779-84. PubMed ID: 22080680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement therapy in Gaucher's and Fabry's disease.
    Pentchev PG
    Ann Clin Lab Sci; 1977; 7(3):251-3. PubMed ID: 404951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
    Altarescu G; Schiffmann R; Parker CC; Moore DF; Kreps C; Brady RO; Barton NW
    Blood Cells Mol Dis; 2000 Aug; 26(4):285-90. PubMed ID: 11042029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of enzyme replacement therapy for Gaucher disease.
    Brady RO; Barranger JA; Gal AE; Pentchev PG; Furbish FS
    Birth Defects Orig Artic Ser; 1980; 16(1):361-8. PubMed ID: 7004519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Velaglucerase alfa for the management of type 1 Gaucher disease.
    Morris JL
    Clin Ther; 2012 Feb; 34(2):259-71. PubMed ID: 22264444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.